Economic efficiency of endoscopic argon plasma coagulation in ulcer gastroduodenal hemorrhage
Aim. To evaluate the cost-effectiveness of acute gastroduodenal bleeding treatment with endoscopic argon plasma coagulation domestic devices. Materials and methods. The study group (n = 1043) consisted of patients who were treated with the use of APC. The control group (n = 158) consisted of patients who were treated using the applicator and injection methods of hemostasis. Estimated economic cost of treating patients and control group. Result. Application of the argon plasma coagulation has reduced the surgical activity of 3.5 times, 2.0 times decreased recurrence of bleeding, reduce the time of hospital treatment for 3 days. The difference of treatment costs amounted cost of treatment costs and control group was 5453 rubles per 1 patient in favor of the main group. Conclusion. The method of endoscopic argon plasma coagulation has a high clinical efficacy while substantially reducing material costs. Developed domestic argon devices with proven high performance at times more affordable foreign counterparts.